Daxor Execs Stack Up Shares, Signaling Confidence Ahead of Blood‑Volume Device Approval
Insider buying at Daxor Corp shows management confidence in a rebounding pipeline, highlighting potential upside ahead of FDA review.
3 minutes to read
Daxor Corp